openPR Logo
Press release

Omega-3 Prescription Drug Market Growth Tied To Cardiovascular Disease Surge: An Emerging Driver Transforming The Omega 3 Prescription Drugs Market Landscape

05-14-2025 11:59 AM CET | Health & Medicine

Press release from: The Business Research Company

Omega 3 Prescription Drugs Market Size

Omega 3 Prescription Drugs Market Size

The Omega 3 Prescription Drugs Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Omega 3 Prescription Drugs Market Size and Projected Growth Rate?
The market size of omega 3 prescription drugs has seen robust growth recently. It's projected to rise from $1.61 billion in 2024 to $1.76 billion in 2025, boasting a compound annual growth rate (CAGR) of 9.5%. The significant growth during the historical period is credited to escalating health awareness, ongoing clinical research, an increased focus on cardiovascular health, medical suggestions, and management of chronic diseases.

The market size of omega 3 prescription drugs is predicted to witness swift expansion in the coming years, reaching $2.61 billion in 2029 with a compound annual growth rate (CAGR) of 10.3%. The anticipated growth during the forecast period can be credited to the broadening indications, transforming consumer tastes, dedicated health solutions, personalized treatments, and growth in clinical evidence. Dominant trends during the forecast period encompass personalized health solutions, enlarged health conditions, innovative formula development, the popularity of health s, along with health applications and wearable devices.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8091

What Are the Major Segments in the Omega 3 Prescription Drugs Market?
The omega 3 prescription drugs market covered in this report is segmented -

1) By Drug Type: Vascepa, Lovaza, Other Type
2) By Application Type: Hypertriglyceridemia, Other Application Type
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

Subsegments:
1) By Vascepa: Pure EPA (Eicosapentaenoic Acid) Formulation, Indications For Cardiovascular Risk Reduction
2) By Lovaza: Combination Of EPA And DHA (Docosahexaenoic Acid), Indications For Hypertriglyceridemia Management
3) By Other Types: Epanova (Omega-3 Carboxylic Acids), Omega-3 Formulations In Clinical Trials, Other Prescription Omega-3 Products

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8091&type=smp

What Are The Driving Omega 3 Prescription Drugs Market Evolution?
The surge in cardiovascular diseases (CVDs) is anticipated to bolster the development of the omega-3 prescription drug market. A higher risk of cardiovascular disorders is related to increased levels of blood triglycerides (a substance similar to fat), and omega-3 s play a crucial role in managing and reducing these triglyceride levels. For example, a 2022 report from the World Health Organization (WHO) stated that cardiovascular diseases (CVDs) continue to be the primary reason for global deaths, accounting for approximately 20.5 million deaths, which comprises nearly one-third of all worldwide fatalities. This demonstrates an uptick from the previously estimated 121 million deaths associated with CVDs. Consequently, the escalation in the incidence of cardiovascular diseases (CVDs) stimulates the expansion of the omega-3 prescription drug market.

Which Firms Dominate The Omega 3 Prescription Drugs Market Segments?
Major companies operating in the omega 3 prescription drugs market include Ionis Pharmaceuticals, Sarepta Therapeutics, Alnylam Pharmaceuticals, Wave Life Sciences, Dyno Therapeutics, BioNTech SE, Moderna Therapeutics, Silence Therapeutics, Arrowhead Pharmaceuticals, ProQR Therapeutics, Regulus Therapeutics, Stoke Therapeutics, Editas Medicine, Beam Therapeutics, Miragen Therapeutics, Biogen Inc., Pfizer Inc., GlaxoSmithKline plc, Arbutus Biopharma, Sanofi S.A., Benitec Biopharma, CRISPR Therapeutics, Dicerna Pharmaceuticals, Translate Bio, PepGen Inc., Sirnaomics Inc., Sterna Biologicals, Genevant Sciences, Genzyme Corporation.

What Trends Are Driving Growth in The Omega 3 Prescription Drugs Market?
The creation of innovative new products is a significant trend that is becoming increasingly popular in the omega-3 prescription drug market. Many prominent companies involved in the production of omega-3 medications are concentrating their efforts on introducing fresh product innovations, with the aim of solidifying their market standing. For instance, in October 2022, DSM received approval from the European Commission to distribute plant-based omega-3 products intended as substitutes for fish and animal products throughout the EU. DSM asserts that this product improves the nutritional profile of plant-based foods, facilitates the production of fish products derived from animals, and mirrors existing fish products. This omega 3 has the potential to boost the nutritional value of products, without negatively impacting the marine environment.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/omega-3-prescription-drugs-global-market-report

Which Is The Largest Region In The Omega 3 Prescription Drugs Market?
North America was the largest region in the omega 3 prescription drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the omega 3 prescription drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Omega 3 Prescription Drugs Market?
2. What is the CAGR expected in the Omega 3 Prescription Drugs Market?
3. What Are the Key Innovations Transforming the Omega 3 Prescription Drugs Industry?
4. Which Region Is Leading the Omega 3 Prescription Drugs Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Omega-3 Prescription Drug Market Growth Tied To Cardiovascular Disease Surge: An Emerging Driver Transforming The Omega 3 Prescription Drugs Market Landscape here

News-ID: 4015387 • Views:

More Releases from The Business Research Company

Segment Evaluation and Major Growth Areas in the Personalized Testing and Supplements Market
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future. Market Valuation and Expansion Forecast for Personalized Testing
Top Players and Market Competition in the Skin Microbiome Industry
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry. Projected Expansion in the Skin
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market Landscape
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory. Steady Growth Expected in Upadacitinib Market Size Through 2029 The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Market
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field. Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics

All 5 Releases


More Releases for Omega

Omega 3 for Pets Market Is Going to Boom | Major Giants Golden Omega, Omega Prot …
HTF MI just released the Global Omega 3 for Pets Market Study, a comprehensive analysis of the market that spans more than 143+ pages and describes the product and industry scope as well as the market prognosis and status for 2025-2033. The marketization process is being accelerated by the market study's segmentation by important regions. The market is currently expanding its reach. Major companies profiled in Omega 3 for Pets Market
Omega Project Review: Omega Project Honest Review: Omega Project
Omega Project Review: Is Aidan Booth's Course Worth Your Investment? In the ever-evolving landscape of online business and digital marketing, finding a course that truly delivers on its promises can be a daunting task. One name that frequently pops up in discussions is Aidan Booth, a seasoned entrepreneur known for his innovative approaches to online marketing. His latest venture, The Omega Project, has garnered significant attention. But does it live up
Omega-3, Omega-6, Omega-9 Market to see tremendous Growth Rate, with Intense Com …
The latest study released on the Global Omega-3, Omega-6, Omega-9 Market by HTF MI evaluates market size, trend, and forecast to 2029. The Omega-3, Omega-6, Omega-9 market study covers significant research data and proofs to be a handy resource document for managers, analysts, industry experts and other key people to have ready-to-access and self-analyzed study to help understand market trends, growth drivers, opportunities and upcoming challenges and about the competitors. Key
Omega-3, Omega-6, Omega-9 Market | Anti-Cancer, Auqi, BASF, Bioprocess Algae
The global omega-3, omega-6, omega-9 market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the omega-3, omega-6, omega-9 market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants. From the perspective of market dynamics, this report explores the factors driving the growth
Omega-3, Omega-6, Omega-9 Market Growth Scenario (2022-2027)
An extensive elaboration of the Omega-3, Omega-6, Omega-9 Market strategy of the industry players in the precision of import/export consumption, supply and demand (2022-2027). The Omega-3, Omega-6, Omega-9 explores a comprehensive study on various segments like opportunities, size, development, innovation, sales, and overall growth of major players. The study is a perfect mix of qualitative and quantitative Market data collected and validated majorly through primary data and secondary sources. Some
Omega-3, Omega-6, Omega-9 Market to Witness Huge Growth by Key Players: DSM, BAS …
The Omega-3, Omega-6, Omega-9 research report undoubtedly meets the strategic and specific needs of the businesses and companies. The report acts as a perfect window that provides an explanation of market classification, market definition, applications, market trends, and engagement. The competitive landscape is studied here in terms of product range, strategies, and prospects of the market's key players. Furthermore, the report offers insightful market data and information about the Omega-3,